CIK 0001738021 · Non-accelerated filer<br>Smaller reporting company
Compass Therapeutics, Inc.
Sign in to watch- Ticker
- CMPX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-500-8099
- Business address
- 80 GUEST STREET, BOSTON, MA, 02135
- Former names
- Olivia Ventures, Inc.
- Open-market buys, last 90 days
- $21,250
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$21,250. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-01 | Lerner Neil Chief Accounting Officer | Purchase | +20,000 | $0.92 | $18K | 420,000 |
| 2026-09-24 | Lerner Neil Chief Accounting Officer | Purchase | +2,500 | $1.14 | $3K | 400,000 |
| 2026-04-29 | Lerner Neil Chief Accounting Officer | Purchase | +15,000 | $1.89 | $28K | 397,500 |
| 2026-04-29 | Anderman Jonathan General Counsel | Purchase | +25,000 | $1.89 | $47K | 196,000 |
| 2025-05-27 | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | Purchase | +10,000 | $2.11 | $21K | 6,480,825 |
| 2025-04-07 | Anderman Jonathan Gen Counsel & Corporate Sec | Purchase | +20,000 | $1.54 | $31K | 21,000 |
| 2025-04-07 | Lerner Neil CHIEF ACCOUNTING OFFICER | Purchase | +20,000 | $1.42 | $28K | 320,000 |
| 2023-03-10 | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | Purchase | +10,000 | $3.37 | $34K | 6,021,873 |
| 2023-02-27 | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | Purchase | +20,000 | $3.98 | $80K | 6,011,873 |
| 2023-02-15 | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | Purchase | +20,000 | $3.86 | $77K | 5,991,873 |
| 2023-01-31 | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | Purchase | +20,000 | $4.05 | $81K | 5,471,873 |
| 2023-01-24 | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | Purchase | +20,000 | $4.19 | $84K | 5,451,873 |
| 2022-11-08 | ORBIMED ADVISORS LLC Director | Purchase | +402,000 | $3.21 | $1.3M | 15,219,994 |
| 2022-11-08 | GORDON CARL L Director | Purchase | +402,000 | $3.21 | $1.3M | 15,219,994 |
| 2022-09-28 | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | Purchase | +10,000 | $2.32 | $23K | 5,431,873 |
| 2022-09-26 | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | Purchase | +15,000 | $2.27 | $34K | 5,421,873 |
| 2022-09-07 | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | Purchase | +15,000 | $3.03 | $45K | 5,406,873 |
| 2022-09-01 | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | Purchase | +15,000 | $2.83 | $42K | 5,391,873 |
| 2022-08-17 | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | Purchase | +15,000 | $3.05 | $46K | 5,376,873 |
| 2022-08-10 | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | Purchase | +15,000 | $2.64 | $40K | 5,361,873 |
Page 1 of 3 · 52 trades